National Vision (EYE) Competitors $10.80 +0.05 (+0.47%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends EYE vs. NVST, IRTC, NVCR, LIVN, WRBY, ENOV, TNDM, TMDX, CNMD, and LMATShould you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), iRhythm Technologies (IRTC), NovoCure (NVCR), LivaNova (LIVN), Warby Parker (WRBY), Enovis (ENOV), Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), CONMED (CNMD), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. National Vision vs. Envista iRhythm Technologies NovoCure LivaNova Warby Parker Enovis Tandem Diabetes Care TransMedics Group CONMED LeMaitre Vascular National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment. Does the media favor EYE or NVST? In the previous week, National Vision had 7 more articles in the media than Envista. MarketBeat recorded 11 mentions for National Vision and 4 mentions for Envista. Envista's average media sentiment score of 0.46 beat National Vision's score of 0.24 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 0 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, EYE or NVST? National Vision has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Envista has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Does the MarketBeat Community favor EYE or NVST? National Vision received 220 more outperform votes than Envista when rated by MarketBeat users. Likewise, 65.46% of users gave National Vision an outperform vote while only 37.78% of users gave Envista an outperform vote. CompanyUnderperformOutperformNational VisionOutperform Votes25465.46% Underperform Votes13434.54% EnvistaOutperform Votes3437.78% Underperform Votes5662.22% Which has higher valuation and earnings, EYE or NVST? National Vision has higher earnings, but lower revenue than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$2.13B0.40-$65.90M-$0.20-54.00Envista$2.50B1.36-$100.20M-$7.77-2.55 Do analysts rate EYE or NVST? National Vision currently has a consensus price target of $13.50, indicating a potential upside of 25.00%. Envista has a consensus price target of $20.21, indicating a potential upside of 1.92%. Given National Vision's stronger consensus rating and higher probable upside, equities research analysts clearly believe National Vision is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Envista 2 Sell rating(s) 10 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07 Is EYE or NVST more profitable? National Vision has a net margin of -0.81% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-0.81% 3.52% 1.39% Envista -53.42%3.76%2.24% SummaryNational Vision beats Envista on 9 of the 16 factors compared between the two stocks. Get National Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EYE vs. The Competition Export to ExcelMetricNational VisionOphthalmic goods IndustryStaples SectorNASDAQ ExchangeMarket Cap$850.50M$11.01B$15.24B$9.06BDividend YieldN/A1.63%2.91%4.02%P/E Ratio-54.0039.7321.3517.34Price / Sales0.405.213.91134.53Price / Cash5.9815.7316.8035.97Price / Book1.023.175.984.80Net Income-$65.90M$235.23M$600.74M$224.91M7 Day Performance2.66%-0.65%1.74%1.90%1 Month Performance-4.00%-2.77%1.75%5.08%1 Year Performance-44.93%-2.79%6.80%21.15% National Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EYENational Vision2.612 of 5 stars$10.80+0.5%$13.50+25.0%-44.9%$850.50M$2.13B-54.0013,998Short Interest ↑News CoverageGap UpNVSTEnvista3.4974 of 5 stars$19.12+2.9%$20.21+5.7%-14.0%$3.29B$2.50B-2.4612,700News CoverageIRTCiRhythm Technologies1.4425 of 5 stars$94.81-3.0%$108.45+14.4%-2.0%$2.97B$560.03M-19.511,790NVCRNovoCure3.1156 of 5 stars$26.67-2.8%$32.67+22.5%+110.7%$2.89B$577.74M-19.051,320Analyst ForecastAnalyst RevisionNews CoverageLIVNLivaNova3.5627 of 5 stars$47.46+1.7%$69.17+45.7%-4.2%$2.58B$1.15B113.002,900Analyst UpgradeWRBYWarby Parker2.3033 of 5 stars$24.97-1.4%$20.73-17.0%+89.3%$2.54B$742.53M-92.483,491Analyst ForecastShort Interest ↓News CoverageENOVEnovis3.0524 of 5 stars$45.34+1.3%$67.00+47.8%-18.9%$2.53B$2.00B-20.706,550Short Interest ↑News CoverageTNDMTandem Diabetes Care4.5431 of 5 stars$35.65-1.0%$53.81+50.9%+45.8%$2.34B$854.35M-18.472,400Positive NewsTMDXTransMedics Group4.2412 of 5 stars$64.71-6.0%$122.70+89.6%-27.3%$2.17B$401.09M68.84210News CoverageCNMDCONMED4.7698 of 5 stars$69.87+1.5%$79.80+14.2%-38.1%$2.16B$1.29B16.604,100LMATLeMaitre Vascular2.8735 of 5 stars$94.11+0.6%$94.57+0.5%+74.1%$2.12B$213.03M51.43490Short Interest ↑News Coverage Related Companies and Tools Related Companies NVST Alternatives IRTC Alternatives NVCR Alternatives LIVN Alternatives WRBY Alternatives ENOV Alternatives TNDM Alternatives TMDX Alternatives CNMD Alternatives LMAT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EYE) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.